Literature DB >> 14521402

Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase.

Séverine Vandevoorde1, Kazuhito Tsuboi, Natsuo Ueda, Kent-Olov Jonsson, Christopher J Fowler, Didier M Lambert.   

Abstract

Cyclohexyl hexadecanoate, hexadecyl propionate, and N-(3-hydroxypropionyl)pentadecanamide, respectively ester, retroester, and retroamide derivatives of N-palmitoylethanolamine, represent the first selective inhibitors of "N-palmitoylethanolamine hydrolase" described so far. These compounds are devoid of affinity for CB(1) and CB(2) receptors and characterized by high percentages of inhibition of N-palmitoylethanolamine-selective acid amidase (84.0, 70.5, and 76.7% inhibition at 100 microM, respectively) with much lower inhibitory effect on either fatty acid amide hydrolase or the uptake of anandamide.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521402     DOI: 10.1021/jm0340795

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

Review 1.  Fatty acid amide signaling molecules.

Authors:  Cyrine Ezzili; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

2.  Activity-Based Probe for N-Acylethanolamine Acid Amidase.

Authors:  Elisa Romeo; Stefano Ponzano; Andrea Armirotti; Maria Summa; Fabio Bertozzi; Gianpiero Garau; Tiziano Bandiera; Daniele Piomelli
Journal:  ACS Chem Biol       Date:  2015-06-23       Impact factor: 5.100

Review 3.  Advances in the discovery of N-acylethanolamine acid amidase inhibitors.

Authors:  Tiziano Bandiera; Stefano Ponzano; Daniele Piomelli
Journal:  Pharmacol Res       Date:  2014-05-04       Impact factor: 7.658

4.  Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.

Authors:  Carlos Solorzano; Francesca Antonietti; Andrea Duranti; Andrea Tontini; Silvia Rivara; Alessio Lodola; Federica Vacondio; Giorgio Tarzia; Daniele Piomelli; Marco Mor
Journal:  J Med Chem       Date:  2010-08-12       Impact factor: 7.446

5.  N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase.

Authors:  Kazuhito Tsuboi; Christine Hilligsmann; Séverine Vandevoorde; Didier M Lambert; Natsuo Ueda
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

6.  Functional disassociation of the central and peripheral fatty acid amide signaling systems.

Authors:  Benjamin F Cravatt; Alan Saghatelian; Edward G Hawkins; Angela B Clement; Michael H Bracey; Aron H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

7.  Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.

Authors:  Carlos Solorzano; Chenggang Zhu; Natalia Battista; Giuseppe Astarita; Alessio Lodola; Silvia Rivara; Marco Mor; Roberto Russo; Mauro Maccarrone; Francesca Antonietti; Andrea Duranti; Andrea Tontini; Salvatore Cuzzocrea; Giorgio Tarzia; Daniele Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-19       Impact factor: 11.205

8.  3-Aminoazetidin-2-one derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors suitable for systemic administration.

Authors:  Annalisa Fiasella; Andrea Nuzzi; Maria Summa; Andrea Armirotti; Glauco Tarozzo; Giorgio Tarzia; Marco Mor; Fabio Bertozzi; Tiziano Bandiera; Daniele Piomelli
Journal:  ChemMedChem       Date:  2014-05-14       Impact factor: 3.466

9.  Molecular mechanism of activation of the immunoregulatory amidase NAAA.

Authors:  Alexei Gorelik; Ahmad Gebai; Katalin Illes; Daniele Piomelli; Bhushan Nagar
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-09       Impact factor: 11.205

10.  The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action.

Authors:  Laurie Hamtiaux; Julien Masquelier; Giulio G Muccioli; Caroline Bouzin; Olivier Feron; Bernard Gallez; Didier M Lambert
Journal:  BMC Cancer       Date:  2012-03-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.